Cite

HARVARD Citation

    Matsumoto, H. et al. (2022). Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non‐small‐cell lung cancer: A multicenter retrospective trial. Thoracic cancer. 13 (2), pp. 228-235. [Online]. 
  
Back to record